Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01210534 · ClinicalTrials.gov registry record
Physiological Brain Atlas Development
A clinical trial of Depression and Parkinson Disease, sponsored by Ohio State University.
- Completed
- Registry status
- 456
- Enrollment target
- 1
- Study location
NCT01210534: Completed study of Depression and Parkinson Disease, sponsored by Ohio State University.
NCT01210534 is a study of Depression and Parkinson Disease that has completed, run by Ohio State University. The registered enrollment target is 456 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01210534, a study of Depression and Parkinson Disease, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 456 participants
- Enrollment target
- 1
- Study location
Study Summary
Enrollment of candidates undergoing a deep brain stimulator (DBS) implant.
Primary Outcome
To create an atlas that will allow physiological information to be assigned to anatomical locations in MRI space, utilizing non-rigid MRI normalization algorithms.
Conditions Studied
Interventions
- OTHER No intervention
Study Locations (1)
Ohio
- The Ohio Sate University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 456 participants |
| Start Date | 2010-08 |
| Est. Completion | 2021-10-18 |
What the finished NCT01210534 record still lists
NCT01210534 is an observational study that tracks outcomes without assigning an intervention. The registered 456 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (42% lower).
The record links to 5 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.
NCT01210534 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT01210534 about?
NCT01210534 is a clinical study titled "Physiological Brain Atlas Development". Enrollment of candidates undergoing a deep brain stimulator (DBS) implant.
What is the current status of trial NCT01210534?
This trial is currently completed. The enrollment target is 456 participants. The study started on 2010-08. Estimated completion is 2021-10-18.
What conditions does trial NCT01210534 study?
This clinical trial studies the following conditions: Depression, Parkinson Disease, Obsessive - Compulsive Disorder, Dystonia, Tremors.
What interventions are being tested in trial NCT01210534?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT01210534?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01210534 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01210534's enrollment target sits among peer trials
456 96th of 679 higher than 583 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Depression and Driving
RECRUITING
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
RECRUITING · Phase 1
-
Identifying and Treating Depression in the Orthopaedic Trauma Population
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04462302 · 456 participants · NA
An Internet-based Program to Help Cancer Survivors Manage Pain
- NCT05820919 · 456 participants · NA
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
- NCT06254612 · 456 participants · Phase 2
A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder
- NCT06457841 · 456 participants · NA
Stress and Resilience
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia